Anti-diabetic nutraceutical from CMFRI soon The Hindu dated 16th May 2016

CMFRI, Library (2016) Anti-diabetic nutraceutical from CMFRI soon The Hindu dated 16th May 2016. The Hindu.

Preview

Text The Hindu_16 May_Antidiabetic nutraceutical.pdf Download (172kB) | Preview

Abstract

An anti-diabetic nutraceutical, Cadalmin, developed by Indian Council of Agriculture Research (ICAR)- Central Marine Fisheries Research Institute (CMFRI), is expected to be available for the public soon. Director, ICAR-CMFRI A. Gopalakrishnan, had recently signed a Memorandum of Understanding with a Hyderabad-based company for commercial production and marketing of Cadalmin in Kochi. The product is effective to combat type-2 diabetes, said a statement issued by the CMFRI here. Cadalmin, which has 100 per cent natural marine bioactive ingredients from selected seaweeds, would be made available in 500 mg capsules by the company. The active ingredients in the product would be packed in plant-based capsules to meet the dietary needs of the large vegetarian population in India and abroad. The nutraceutical is prepared from seaweeds, which are commonly available in the Indian coastal waters. Seaweeds are the natural bounty of the sea and are known for their medicinal properties.

Actions (login required)

View Item